We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTX icon
51
MarketAxess Holdings
MKTX
$5.71B
$48.3M 0.5%
239,493
-5,855
-2% -$1.1M
CMCSA icon
52
Comcast
CMCSA
$85B
$46.7M 0.48%
1,167,207
-31,720
-3% -$1.19M
AVGO icon
53
Broadcom
AVGO
$1.85T
$46.7M 0.48%
1,818,050
-272,040
-13% -$7.07M
EL icon
54
Estee Lauder
EL
$30.4B
$46.2M 0.48%
363,171
-9,193
-2% -$1.1M
RTX icon
55
RTX Corp
RTX
$290B
$45.6M 0.47%
568,408
-60,575
-10% -$4.6M
CTAS icon
56
Cintas
CTAS
$81.9B
$44M 0.45%
1,129,348
-32,084
-3% -$1.22M
PX
57
DELISTED
Praxair Inc
PX
$43.2M 0.44%
279,060
-709
-0.3% -$105K
KO icon
58
Coca-Cola
KO
$377B
$43M 0.44%
938,199
-13,466
-1% -$619K
UNH icon
59
UnitedHealth
UNH
$376B
$42.1M 0.43%
191,155
-3,017
-2% -$639K
MCD icon
60
McDonald's
MCD
$192B
$40.6M 0.42%
235,653
+4,727
+2% +$794K
SBUX icon
61
Starbucks
SBUX
$120B
$39.2M 0.4%
682,495
+3,046
+0.4% +$172K
PSA icon
62
Public Storage
PSA
$60.5B
$39.2M 0.4%
187,367
-23,890
-11% -$5.05M
NKE icon
63
Nike
NKE
$61.9B
$34.3M 0.35%
547,708
-1,271
-0.2% -$73.1K
VGT icon
64
Vanguard Information Technology ETF
VGT
$139B
$31.3M 0.32%
1,521,744
+10,496
+0.7% +$213K
STZ icon
65
Constellation Brands
STZ
$22.2B
$30M 0.31%
131,226
+33,242
+34% +$7.19M
CDW icon
66
CDW
CDW
$18.9B
$28.4M 0.29%
408,370
-8,871
-2% -$610K
DIS icon
67
Walt Disney
DIS
$167B
$27.6M 0.28%
256,876
-43,862
-15% -$4.52M
ECL icon
68
Ecolab
ECL
$78.1B
$26.9M 0.28%
200,576
-989
-0.5% -$132K
WSO icon
69
Watsco Inc
WSO
$12.7B
$25.4M 0.26%
149,617
+11,935
+9% +$1.97M
NVS icon
70
Novartis
NVS
$297B
$22.9M 0.24%
304,864
+222
+0.1% +$16.8K
WFC icon
71
Wells Fargo
WFC
$261B
$22.1M 0.23%
363,903
-9,800
-3% -$553K
TJX icon
72
TJX Companies
TJX
$174B
$21.8M 0.22%
571,196
-105,306
-16% -$3.82M
FAST icon
73
Fastenal
FAST
$54.7B
$21.6M 0.22%
1,580,508
-48,516
-3% -$601K
HPQ icon
74
HP
HPQ
$24.9B
$21.5M 0.22%
1,024,011
+996,093
+3,568% +$21.2M
RPM icon
75
RPM International
RPM
$13.7B
$20.2M 0.21%
386,178
+13,276
+4% +$694K

Similar funds

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.